nky 722 has been researched along with thromboxane a2 in 1 studies
| Studies (nky 722) | Trials (nky 722) | Recent Studies (post-2010) (nky 722) | Studies (thromboxane a2) | Trials (thromboxane a2) | Recent Studies (post-2010) (thromboxane a2) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 5,617 | 224 | 429 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashizume, Y; Ishimitsu, T; Kanda, M; Nakamura, S; Shimaji, H; Shirahase, H; Uehara, Y; Wada, K | 1 |
1 other study(ies) available for nky 722 and thromboxane a2
| Article | Year |
|---|---|
Protective effect of the calcium antagonist NKY-722 against renal and arterial injuries in Dahl salt-sensitive rats.
Topics: Animals; Aorta, Thoracic; Arteries; Blood Pressure; Calcium Channel Blockers; Cerebral Arteries; Dihydropyridines; Epoprostenol; Hypertension; Kidney; Male; Nicardipine; Rats; Renal Artery; Thromboxane A2 | 1994 |